Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oncology Reports|August 5, 2015
The complex liaison between cachexia and tumor burden (Review)Andrea De Lerma Barbaro
The Breast Journal|November 6, 2010
New strategies of mammary cancer vaccinationRoberto S Accolla, Valeria Frangione, Andrea De Lerma Barbaro, et al.
International Immunology|April 28, 2009
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functionsLorenzo Mortara, Valeria Frangione, Patrizia Castellani, et al.
International Journal of Cancer|January 22, 2010
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapyValeria Frangione, Lorenzo Mortara, Patrizia Castellani, et al.
Cancer Metastasis Reviews|December 19, 2007
Inflammation, inflammatory cells and angiogenesis: decisions and indecisionsDouglas M Noonan, Andrea De Lerma Barbaro, Nicola Vannini, et al.
European Journal of Immunology|October 2, 2002
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replicationRoberto S Accolla, Stefania Mazza, Andrea De Lerma Barbaro, et al.
Vaccines|January 24, 2025
Efficacy of Anti-Cancer Immune Responses Elicited Using Tumor-Targeted IL-2 Cytokine and Its Derivatives in Combined Preclinical TherapiesSahar Balkhi, Giorgia Bilato, Andrea De Lerma Barbaro, et al.
Insects|August 25, 2019
In Vivo Effects of A Pro-PO System Inhibitor on the Phagocytosis of Xenorhabdus Nematophila in Galleria Mellonella LarvaeAndrea De Lerma Barbaro, Marzia B Gariboldi, Maristella Mastore, et al.
Surgical Oncology|November 24, 2007
Experimental therapeutic approaches to adenocarcinoma: the potential of tumor cells engineered to express MHC class II molecules combined with naked DNA interleukin-12 gene transferLorenzo Mortara, Luca Giuliani, Andrea De Lerma Barbaro, et al.
International Journal of Immunogenetics|May 9, 2025
The Quest for Antibodies and Other Acquired Immune Receptors: A Historical PerspectiveAndrea De Lerma Barbaro, Sahar Balkhi, Stefano Giovannardi, et al.
Pageof 3